7.25
-0.30 (-3.97%)
-0.30 (-3.97%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cyclacel Pharmaceuticals Inc | CYCC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.30 | -3.97% | 7.25 | 18:14:58 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.49 | 7.10 | 7.63 | 7.21 | 7.55 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 7.21 | 7.25 | 0.04 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,352 | 209,156 | $ 7.33 | $ 1,532,256 | 781,303 | 3.12 - 19.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:14:58 | formt | 5,000 | $ 7.25 | USD |
Cyclacel Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 35.26M | 4.86M | 4.82M | $ - | $ - | -9.89 | -1.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cyclacel Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYCC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.92 | 9.46 | 7.10 | 7.70 | 466,296 | -1.67 | -18.72% |
| 1 Month | 6.35 | 9.77 | 6.19 | 8.26 | 576,801 | 0.90 | 14.17% |
| 3 Months | 3.31 | 9.77 | 3.12 | 6.75 | 458,728 | 3.94 | 119.03% |
| 6 Months | 4.48 | 9.77 | 3.12 | 5.82 | 321,834 | 2.77 | 61.83% |
| 1 Year | 16.00 | 19.25 | 3.12 | 5.88 | 421,687 | -8.75 | -54.69% |
| 3 Years | 33.20 | 38.60 | 3.12 | 12.75 | 317,685 | -25.95 | -78.16% |
| 5 Years | 6.36 | 218.00 | 3.12 | 44.80 | 344,828 | 0.89 | 13.99% |
Cyclacel Pharmaceuticals Description
| Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom. |
